Share on Pinterest
MarkHatfield/Getty Images

We admit products we think are useful for our readers. If you bribe through and through links on this pageboy, we may earn a small commission. Here's our process.

For anyone winning long and short-acting (pre-meal) insulin, an insulin pump offers freedom from every last of the molest of injections.

If you settle to feed a little more, or do some unplanned example, you can just push a button to allot much or fewer insulin. And the pump's continuous background drip of insulin mimics the military action of a healthy pancreas, so your blood glucose levels can remain much steadier.

Traditionally, insulin pumps were stand firm-exclusive devices. Merely in modern years, they're more and more connected to a ceaseless glucose monitor (CGM) to create a more machine-driven glucose monitoring and insulin dosing combo marketed as a "closed closed circuit system."

Whether the pump is engaged to a CGM or non, the person wearing it still plays an important role in determining how much insulin they deman and when they need it, specially around meals.

But no worries — ultramodern pumps are very intuitive and easy to use. And there's no old age limit on using a pump; they are used by children, totally the way up to old adults.

Show on to learn about current insulin pumps in the United States authorised by the FDA (FDA), some older models even in apply, and a glance at next-gen insulin pump engineering science that's on the horizon.

Here is a rundown of the existing insulin pumps on the market in the United States (listed in alphabetical order) and what they offer to people with diabetes:

Tandem t:slim X2

The X2 is the latest iteration of the signature touchscreen insulin heart from California fellowship Tandem Diabetes Tutelage, first introduced back in 2012. The X2 has built-in Bluetooth connectivity, and received FDA headroom in 2016. It was launched to market the succeeding year.

Tandem's t:slim X2 is a traditional tubed insulin pump, significant insulin is delivered via a long plastic cannula adjoining to the body via an extract localize. What makes it stand out from competitors are the color touchscreen display and innovative insulin cartridge design. Tandem's pickup uses a bag of insulin instead than a clear, steely-case reservoir at bottom like most of the other tubed pumps.

What's also unusual about t:slim X2 is the capacity to update the unit remotely from home, a first in the diabetes pump world. This means users rear end update the pump's features fair-and-square by plugging the device into a computer and connecting to Tandem's updater site, rather than needing to buy a whole new expensive piece of ironware.

The current iterations of this pump bring more closed-loop system capabilities: either an auto-insulin shutoff have known as Basal-IQ, launched in 2018, or their more advanced Control-IQ algorithm, launched in early 2020, that auto-adjusts insulin deliverance to offset printing swollen blood sugars.

Currently, this pump only works with the Dexcom CGM, simply Bicycle-built-for-two has agreements for future integrating with other CGMs, including the Abbott FreeStyle Libre flash glucose monitor lizard.

Medtronic Minimed 670G and 770G Intercrossed Closed Loop

Medtronic has been a long-metre leader in tubed insulin pump technology. They are also the but company that manufactures some a pump and a CGM.

In fact, Medtronic is the oldest ticker company on the market, kickoff with their acquisition of Minimed back in 2001. Their traditonal horizontally-oriented pumps looked similar to pagers, just those older iterations have now formally been out of print and replaced with the "6-serial" that have a more modern look and vertical orientation course.

Their Minimed 670G was FDA-authorized in 2016 as the first-always "hybrid closed loop system" that can automatically monitor glucose and adjust basal insulin doses, authorised for use away people 14 and older with type 1 diabetes (T1D). Thae 670G monitors glucose using Medtronic's Tutelary 3 CGM and automatically adjusts essential insulin to keep users Eastern Samoa close as manageable to the regressive target roue sugar level of 120 mg/dL.

It has the ability to predictively alert users to impending low blood sugars, and can adjust insulin accordingly or shut off backdrop insulin if the user reaches a devalued threshold. It was dubbed a "hybrid" closed loop upon launching because it does non take over glucose control completely as is awaited from a sonorous ersatz pancreas.

You can say about users' experiences with the 670G in our review here.

In 2020, Medtronic launched the 770G. With the selfsame form factor as the 670G, this newer model adds Bluetooth connectivity so that IT can mould with smartphone apps. Importantly, this system is FDA approved for adults and kids American Samoa young as 2 years old right from the start — instead of starting with adults and doing pediatric studies later, which is traditionally the case.

This 770G version is also the platform that will be misused for the company's tense tech, which is a more advanced and personalized compressed loop system. This is the pump that Medtronic is now selling Eastern Samoa it's most current model in the United States, and updating those who have been using the sooner models.

Omnipod tubeless speckle pump

The simply full-conspicuous tubeless insulin pump on the market is made away the Boston-area company Insulet Corp.

Premiere launched in 2005, this system of rules has gone done a few iterations earlier the Omnipod DASH arrangement was released in 2019. Insulin is delivered via a small fuel pod with an stick-on back that's stuck onto your skin, that is controlled via wireless connection to a hand-held PDM (Personal Diabetes Handler). The Pall good example has built-in Bluetooth and touchscreen PDM with color display.

The newest Omnipod also no more houses a built-in fingerstick glucose meter as earlier models did.

Omnipod doesn't currently permit for remote of insulin delivery via a mobile smartphone app. But that is forthcoming soom in the newest Omnipod 5 sit (formerly known as Omnipod Horizon), which will exist Insulet's first closed loop tech that works with the Dexcom G6 CGM. That is awaited in belated 2021 OR early 2022.

While insulin pumps have largely been aimed at the T1D population of people on intensive insulin therapy, information shows these devices can have a huge benefit for those living with typewrite 2 diabetes (T2D) who use insulin likewise.

Beyond the above-mentioned pumps, there are two other pump devices aimed specifically at the character 2 universe:

Valeritas V-Go

This simple, daily-use disposable "while ticker" was launched book binding in 2011, and in 2019 announced a milestone of 20 million devices sold.

The stick-on darn building block (with no fictile tube) holds unrivaled day's worth of fast-playing insulin, and is preset to deliver unmatchable of cardinal geostationary basal (background insulin) rates for the day.

Despite the large drug user base, the manufacturer Valeritas filed for bankruptcy in 2020 and sold the V-Go to Denmark-based biotech crisp Seeland Pharma, which also has a rescue glucagon playpen now available in the United States.

Through the V-Go ware page, you stern find more information about this device you bet to get down the process to buy ace.

Omnipod U-500 Pods

Omnipod-manufacturer Insulet has been talking about its interest in oblation a high-centralised insulin delivery device aimed at the T2D universe for a number of old age now.

The new pods would employment Eli Lilly's higher-concentrated U-500 insulin, which would make the tubeless pump a real pick for patients World Health Organization need large amounts of insulin, which is the subject for many people with T2D. This remains in exploitation arsenic of 2021 and there is no official timeline on when this might get ahead available.

Medtronic's 780G model

The 780G model is acknowledged as the High-tech Hybrid Closed-loop system (ACHL), and it's currently pending revaluation before the FDA in middle-2021.

Information technology looks the same as the 670G and 770G, but it will also let in advanced features:

  • an auto-correction bolus every 5 minutes to help keep users in optimal swan and car-adjust for missed meals
  • adjustable glucose target between 100 to 120 Mg/dL (compared to the circulating unmoving target at 120 magnesium/deciliter)
  • inherent Bluetooth for data-share-out and inaccessible monitoring
  • all over-the-air software updates (similar to Tandem's) soh users won't have to buy in a integral new gimmick each time an improvement is available

Medtronic is evangelical about customers being capable to easily ascent to 780G and newer features remotely, rather than requiring a new hardware purchase. FDA approval is due in the second half of 2021, with a launch following that.

t:sport miniskirt pump

A new Tandem mini pump in the kit and boodle is known internally as "t:sport," though that may not be the formalized brand name when it hits market. It will be a hybrid of sorts, roughly half the size up of the extant t:reduce X2 pump and without some display riddle at all.

Notably, this will be a patch pump with nary tubing, that includes a English-button to administer a quick insulin window pane direct from the device itself. The t:sport wish stick the skin with an stick-on, but unlike the Omnipod, would be detachable for short periods of clock time.

The promise is to give customers a choice of how they want to use it: either via smartphone app, or a separate receiving system device. In tandem had originally planned to submit this to FDA for consideration by mid-2020, but delays due to the COVID-19 crisis have pushed that timeline back.

While these insulin pumps are no yearner made Beaver State sold to new customers in the United States, many are still circulating, used by rock-ribbed fans and in some cases, get along-information technology-yourselfers WHO've dependant these older models busy their have homemade connected systems. Many people still obtain these insulin pumps to use, scorn non existence able to buy them directly from manufacturers or most third-party suppliers.

Medtronic's before Minimed pumps

In its heyday, the Minimed 530 was monumental because it did what none other insulin pump had done before: Information technology automatically suspended insulin delivery if you crossed a certain low glucose threshold. Medtronic snagged FDA approval for that Low Glucose Suspend (LGS) operating theatre threshold-suspend characteristic in Sep 2013 and IT remained available until Oct 2018, when Medtronic out of print it and originally "5-serial" pumps pro the newer 6-series devices.

Share on Pinterest

The discontinuation of those classic Medtronic pump models that looked like colorful pagers noticeable the end of an era. The Minimed Revel and Paradigm designs, as advantageously as the 530G (with auto-shutoff for low blood sugars), are actually silent widely ill-used but are no longer being manufactured OR sold aside the company. The supplies are proper more difficult to find as time moves forward.

Animas pumps

Unmatched of the oldest brands of pumps was Animas, which stumble market in the rude 2000s and became part of drug company giant star Johnson & President Johnson. The popular Animas Ping and Vibe insulin pumps were the latest in a long line of their tubed insulin pumps direct the days.

Unluckily Animas was shut down October 2017, after J&J announced it would embody closing its pump division for good.

The company obstructed manufacturing its devices and transferred remaining customers to Medtronic for supplies and pump support up until 2019. Some hoi polloi are static using Animas devices, but with different infusion sets and supplies obtained through third-party vendors.

Roche Accu-Chek

Another longtime insulin pump manufacturer was Roche Diabetes Care, with its Accu-Chek pump line. In 2003, Roche noninheritable Disetronic and used that as base technology to eventually rebrand and plunge the Accu-Chek Spirit pump in 2006.

That evolved through the eld, but Roche one of these days stopped marketing this ticker in the The States in early 2017, and transferred every last remaining customers to Medtronic for support and supplies. Like Animas in 2019, customers were then forced to swap pump brands or put through thirdly-party suppliers to continue using the unit. While Roche hasn't shut the threshold on sooner or later bringing a new pump book binding to the U.S. market in future years, there's nary guarantee.

The future of insulin pumping unquestionably appears to comprise connecting these devices to CGMs for better blood glucose control. This naturally has pushed to the forefront the issue of gimmick interoperability and homemade (DIY) technology.

Behind this evolution has been pressure from the persevering community rallying behind a #WeAreNotWaiting mantra — pushing to commence innovative applied science out more quickly and allow data and gimmick integration.

Many of the folks creating DIY connected systems are using older, out of print insulin pumps such every bit the Minimed Revel and Paradigm models. Despite an FDA warning and mainstream media concern that surfaced in 2019, thousands of people are immediately safely and successfully using these homemade systems.

In the meantime, FDA has published new interoperability protocols to help the well-grooved medtech industry produce products that are more "modular" and toilet work together safely and seamlessly. For insulin pumps like the Tandem t:slim X2, that agency gaining a exceptional appellation from the FDA marking that new pump as "interoperable technology."

This is important to keep out in nou when shopping for new insulin ticker technology.

This can Be a tricky interrogate, because when it comes to diabetes technology the cost often varies based on one's insurance coverage.

Generally, you can spend thousands of dollars connected the initial purchase because you'Ra buying a virgin device on with that first set of supplies to use it. The protrusive cost lav make up anywhere from $3,000 to $8,000 depending on the device, and monthly supplies rump also add up quickly. Just about companies do offer defrayment plans, besides.

Keep in mind, this is merely the first-meter buy and doesn't include the required pump supplies — including extract sets, tube, cartridges operating room reservoirs for insulin, as well as adhesives wipes for internet site preparation. Of course, you'd also need to purchase the insulin to fill the ticker and whatever separate CGM supplies that you might utilization aboard this ticker.

Even with insurance, it can cost hundreds of dollars per month to afford an insulin pump.

Most private indemnity companies cut through insulin pumps low the durable medical equipment (DME) portion of the insurance policy. You'll need to exploit with a doctor to get a prescription and Missive of Medical Necessity substantiative your diagnosis and medical need.

The paperwork can be somewhat daunting, so most insulin pump companies offer help in the form of dedicated insurance serving teams that crop with patients to apply for insurance coverage.

The terms of coverage vary('Your Insurance May Vary' is a well-known mantra in our Diabetes Community), and your choice of covered device may personify limited because many insurance companies have "preferred" deals with certain pump makers.

This became quite controversial after Medtronic gestural an exclusive deal with Conjunctive Health care (UHC) in 2016, locking their members in to that stigmatise of pump only.

A twin deal followed in 2019 for the latest Medtronic tech approved for children. While UHC and Medtronic take a firm stand that exceptions can live made in certain cases, many plan members saved they weren't able-bodied to obtain a not-Medtronic pump of their option. Fortunately as of July 1, 2020, UHC began offering a choice aside expanding their reporting to admit Tandem pumps along with Medtronic's.

Health insurance policy hurdles can definitely add an additional layer of difficultness in trying to decide which insulin ticker is your uncomparable choice.

This really depends along many factors, both person-to-person and institutional. Thus many different things perish into extraordinary's selection on a bear-sized diabetes device purchase like this, ranging from the specific features you prefer, to how it works with other technology and smartphones, and whether information technology includes tube or is a tubeless tire patch pump.

Get at and affordability are besides huge factors that make this decision for more people, because insurance policy plans father't always care to cover expensive medical devices the likes of these or they have specific criteria that must be met in ordination to buy in a particular insulin pump.

Speaking to your healthcare professional about the different options and what might work top-quality for your diabetes management is always advisable, as well as reviewing credible and reliable information online about how the various technologies work on.

User reviews can as wel make a full-size difference in deciding on which insulin pump may be right for you. You can starting signal by checking out our mathematical product reviews here at DiabetesMine on Medtronic, Omnipod and Tandem pumps.

For some PWDs, the tubeless Omnipod is an easy choice because it's the simply patch pump currently available in the United States. But for those WHO put on't precaution approximately wearing tubing, the more modern-looking Tandem t:slim X2 is appealing to umpteen because of its emblazon touchscreen and its connectivity to the Dexcom G6 CGM. Yet, the semipermanent sustainability of a company like Medtronic brings market acknowledgement and many healthcare professionals continue turning thereto firebrand.

As the saying goes, it all depends happening you and what's important for your life with diabetes.

Insulin pumps can be a great selection for both adults and children with diabetes. They offer a ton of flexibleness and features to help you optimize your glucose ascertain. But that doesn't poor an insulin pump is the only option or the treatment that works best for everyone. Here's a guide to making your own decision whether to heart or non.

Innovative pumps get multiple features that can allow for more customization in how you care diabetes, as well atomic number 3 the different supplies that you apply. While these are costly gadgets that insurance isn't always eager to cut through, insulin pumps are helping many an PWDs live fitter, less onerous lives.